ESCMID 2026: Antiretroviral Therapy Significantly Reduces Accelerated Biological Ageing in People with HIV

The Swiss HIV Cohort Study (SHCS), presented at ECSMID Global 2026 in April, shows that accelerated biological ageing in people with HIV, which is linked to chronic inflammation and coronary diseases, is reduced by almost four years following antiretroviral therapy (ART).

This article is based on a press release issued in connection with the ESCMID Global Congress 2026. The study abstract is referenced below.